AMGEN INC (AMGN)
Clinical trial NCT05094336 updates: 1. completion date: 2028-05-29 → 2026-11-30 2. primary completion date: 2026-05-27 → 2026-11-30 3. enrollment: not set → 329 participants
Clinical trial NCT05094336 updates: 1. completion date: 2028-05-29 → 2026-11-30 2. primary completion date: 2026-05-27 → 2026-11-30 3. enrollment: not set → 329 participants
📉 **NEGATIVE** • Medium confidence analysis (72%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (18%) **Content type:** Clinical